What does the current research say about safety
Ozempic for CKD and heart disease The FLOW phase 3b clinical trial (NCT03819153) demonstrated that when Ozempic 1 mg injection was used in adults with type 2 diabetes and CKD, Ozempic demonstrated: 24% reduced the risk of kidney disease progression, kidney failure, and cardiovascular death at 3 years when compared to placebo
Of these, at least 8 days per month have other features of migraine, such as aura, nausea, and heightened sensitivity to light and sound
Less Common but More Serious Risks Although uncommon, more serious adverse effects have been reported and require medical evaluation
17 Menopause increases the risk of cardiometabolic diseases like type 2 diabetes mellitus (T2DM), high cholesterol levels, fatty liver, and cardiovascular disease (CVD), the latter being the leading killer among women
Quick Answer: GLP-1 probiotics lack robust clinical evidence for meaningful weight loss and are not FDA-approved alternatives to prescription medications like semaglutide or tirzepatide